Zacks Investment Research on MSN1 天
PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study
Pacira BioSciences PCRX announced that it has dosed the first patient in a mid-stage study of pipeline candidate PCRX-201 ...
The Poultry Site4 天
Two key factors in a robust IBD defense: Speed of replication and onset of immunity
Two important contributors of early protection are speed of replication and onset of immunity, according to Alberto Giner, ...
EurekAlert!6 天
MOPEVACLAS vaccine candidate for Lassa fever enters clinical trials
After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut ...